Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Autologous Serum Intrastromal Injection for Corneal Diseases
NCT05944757Unknown
- Start
- Sep 2021
- Primary completion
- Sep 2023
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Open-label trial of platelet-rich plasma in dry eye syndrome (DED), keratoconus and Corneal dystrophy (2 arms). Primary endpoint: Improving dry eye symptoms at 12 months. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
dry eye syndrome (DED)keratoconusCorneal dystrophy
Beyond the preview
Go deeper on NCT05944757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944757.